This study confirmed that RET p.Val804Met was indeed typically associated with later onset of MTC than typical for other pathogenic germline RET mutations but asserted that albeit of later onset, penetrance for disease was nevertheless near complete (28). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.